Works matching DE "CHRONIC myeloid leukemia"

Results: 5000
    1
    2
    3
    4
    5

    Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 1, p. 114, doi. 10.2298/VSP180723010D
    By:
    • Denčić-Fekete, Marija;
    • Leković, Danijela;
    • Djordjević, Vesna;
    • Jovanović, Jelica;
    • Todorić-Živanović, Biljana;
    • Jaković, Ljubomir;
    • Bogdanović, Andrija
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action.

    Published in:
    Biological Trace Element Research, 2020, v. 197, n. 1, p. 123, doi. 10.1007/s12011-019-01976-0
    By:
    • de Lima, Aliny Pereira;
    • Almeida, Marcio Aurélio Pinheiro;
    • Mello-Andrade, Francyelli;
    • de Castro Pereira, Flávia;
    • Pires, Wanessa Carvalho;
    • Abreu, Davi Carvalho;
    • de Souza Velozo-Sá, Vivianne;
    • Batista, Alzir Azevedo;
    • de Paula Silveira-Lacerda, Elisângela
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19

    Sex differences in the incidence of chronic myeloid leukemia.

    Published in:
    Radiation & Environmental Biophysics, 2014, v. 53, n. 1, p. 55, doi. 10.1007/s00411-013-0507-4
    By:
    • Radivoyevitch, Tomas;
    • Jankovic, Gradimir;
    • Tiu, Ramon;
    • Saunthararajah, Yogen;
    • Jackson, Robert;
    • Hlatky, Lynn;
    • Gale, Robert;
    • Sachs, Rainer
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7103, doi. 10.1007/s00432-023-04662-w
    By:
    • Deręgowska, Anna;
    • Pępek, Monika;
    • Solarska, Iwona;
    • Machnicki, Marcin M.;
    • Pruszczyk, Katarzyna;
    • Dudziński, Marek;
    • Niesiobędzka-Krężel, Joanna;
    • Seferyńska, Ilona;
    • Sawicki, Waldemar;
    • Wnuk, Maciej;
    • Stokłosa, Tomasz
    Publication type:
    Article
    28
    29

    Quo vadis precision oncology?

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 1, p. 3, doi. 10.1007/s00432-022-04478-0
    By:
    • Heinrich, Kathrin;
    • Westphalen, C. Benedikt
    Publication type:
    Article
    30
    31

    Health-related quality of life in children with chronic myeloid leukemia in the chronic phase.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 2, p. 341, doi. 10.1007/s00432-021-03832-y
    By:
    • Zheng, Fangyuan;
    • Dou, Xuelin;
    • Zhang, Liqiang;
    • Jin, Jie;
    • Zhang, Yanli;
    • Liu, Bingcheng;
    • Meng, Li;
    • Zhu, Xiaofan;
    • Lu, Zesheng;
    • Jia, Yueping;
    • Liu, Huilan;
    • Lin, Hai;
    • Zhou, Li;
    • Zhao, Xielan;
    • Yang, Wei;
    • Sun, Hui;
    • Qian, Sixuan;
    • Ma, Hongxia;
    • Wu, Runhui;
    • Zhang, Leping
    Publication type:
    Article
    32
    33
    34

    Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 10, p. 3081, doi. 10.1007/s00432-021-03569-8
    By:
    • Schäfer, Vivien;
    • White, Helen E.;
    • Gerrard, Gareth;
    • Möbius, Susanne;
    • Saussele, Susanne;
    • Franke, Georg-Nikolaus;
    • Mahon, François-X.;
    • Talmaci, Rodica;
    • Colomer, Dolors;
    • Soverini, Simona;
    • Machova Polakova, Katerina;
    • Cross, Nicholas C. P.;
    • Hochhaus, Andreas;
    • Ernst, Thomas
    Publication type:
    Article
    35

    Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1645, doi. 10.1007/s00432-019-02910-6
    By:
    • Möbius, Susanne;
    • Schenk, Thomas;
    • Himsel, Danny;
    • Maier, Jacqueline;
    • Franke, Georg-Nikolaus;
    • Saussele, Susanne;
    • Pott, Christiane;
    • Andrikovics, Hajnalka;
    • Meggyesi, Nora;
    • Machova-Polakova, Katerina;
    • Zizkova, Hana;
    • Jurcek, Tomáš;
    • Mesanovic, Semir;
    • Zadro, Renata;
    • Gottardi, Enrico;
    • Haenig, Jens;
    • Schuld, Peter;
    • Cross, Nicholas C. P.;
    • Hochhaus, Andreas;
    • Ernst, Thomas
    Publication type:
    Article
    36

    Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1589, doi. 10.1007/s00432-019-02894-3
    By:
    • Cortes, Jorge E.;
    • Gambacorti-Passerini, Carlo;
    • Deininger, Michael W.;
    • Mauro, Michael J.;
    • Chuah, Charles;
    • Kim, Dong-Wook;
    • Milojkovic, Dragana;
    • le Coutre, Philipp;
    • Garcia-Gutierrez, Valentin;
    • Crescenzo, Rocco;
    • Mamolo, Carla;
    • Reisman, Arlene;
    • Hochhaus, Andreas;
    • Brümmendorf, Tim H.
    Publication type:
    Article
    37
    38
    39

    Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 5, p. 1041, doi. 10.1007/s00432-015-2101-4
    By:
    • El Missiry, Mohamed;
    • Adnan Awad, Shady;
    • Rajala, Hanna L;
    • Al-Samadi, Ahmed;
    • Ekblom, Marja;
    • Markevän, Berit;
    • Åstrand-Grundström, Ingbritt;
    • Wold, Maren;
    • Svedahl, Ellen;
    • Juhl, Birgitte;
    • Bjerrum, Ole;
    • Haulin, Inger;
    • Porkka, Kimmo;
    • Olsson-Strömberg, Ulla;
    • Hjorth-Hansen, Henrik;
    • Mustjoki, Satu
    Publication type:
    Article
    40
    41
    42

    The Anti-Leukemic Activity of Natural Compounds.

    Published in:
    Molecules, 2021, v. 26, n. 9, p. 2709, doi. 10.3390/molecules26092709
    By:
    • Cotoraci, Coralia;
    • Ciceu, Alina;
    • Sasu, Alciona;
    • Miutescu, Eftimie;
    • Hermenean, Anca;
    • Fabiani, Roberto
    Publication type:
    Article
    43
    44
    45
    46
    47

    Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity.

    Published in:
    Molecules, 2019, v. 24, n. 19, p. 3535, doi. 10.3390/molecules24193535
    By:
    • I. Ciftci, Halil;
    • O. Radwan, Mohamed;
    • E. Ozturk, Safiye;
    • Ulusoy, N. Gokce;
    • Sozer, Ece;
    • E. Ellakwa, Doha;
    • Ocak, Zeynep;
    • Can, Mustafa;
    • F.S. Ali, Taha;
    • I. Abd-Alla, Howaida;
    • Yayli, Nurettin;
    • Tateishi, Hiroshi;
    • Otsuka, Masami;
    • Fujita, Mikako;
    • Sekeroglu, Nazim;
    • Kijjoa, Anake;
    • Gezici, Sevgi
    Publication type:
    Article
    48
    49
    50